☆ 4.1 Editorial Material

TMPRSS2: Potential Biomarker for COVID-19 Outcomes

JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Get Full Text
Add to Collection

Journal

JOURNAL OF CLINICAL PHARMACOLOGY
Volume 60, Issue 7, Pages 801-807

Publisher

WILEY
DOI: 10.1002/jcph.1641

Keywords

biomarker; coronavirus; COVID-19; SARS-CoV-2; TMPRSS2

Categories

Pharmacology & Pharmacy

Funding

  1. Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health
  2. NATIONAL CANCER INSTITUTE [ZIABC011974] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.